← Back to LPCN

Lipocine Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 05/08/2025Mar 2024Filed 08/05/2025
$0.2$0.1$0.1$0.6$0.1$0.1$7.6
−$2.6−$3.7−$3.2−$2.2−$1.9−$2.2−$3.1$3.5
−$0.32−$0.54−$0.59−$0.41−$0.35−$0.44−$0.56$0.66
8.26.85.45.45.35.35.35.4

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.